Latest Regulatory Approvals News

Nyrada has secured ethics approval to begin a pivotal Phase IIa trial of its drug Xolatryp, targeting heart attack damage. Patient dosing is set to start in March 2026 across multiple Australian hospitals.

Fatfish Group Limited has refinanced its $5.67 million debt with Arena Investors LP and secured an additional $0.15 million through new convertible notes, including a board nomination right for Arena.

BPH Global has refined its Project 6-7 R&D program to concentrate on recovering gold and silver from seaweed, aiming to fast-track commercialisation of this innovative bio-mining approach.

Canyon Resources advances its Minim Martap Bauxite Project with mining set to start in February 2026 and first shipments targeted for late June, underpinned by key operational milestones and strategic partnerships.

Estrella Resources has gained regulatory approval to extract a 30,000-tonne bulk sample of high-grade manganese from its Ira Miri project, marking a pioneering step for Timor-Leste’s mining sector under its modern Mining Code.

Critical Resources has engaged SLR Consulting to streamline permitting for its Mavis Lake Lithium Project in Ontario, aiming to fast-track approvals and secure government funding. This move strengthens the project’s role in North America’s lithium supply chain amid growing demand for sustainable battery materials.

Lindian Resources reports strong construction progress at its Kangankunde Rare Earths Project in Malawi, highlighted by the arrival of its Komatsu owner-operator mining fleet and advancing infrastructure works.

Lunnon Metals has secured the last regulatory approval needed to advance its Lady Herial gold project, bringing it closer to production under a key agreement with St Ives Gold Mining.

Hydrix Limited’s subsidiary has landed a significant A$2.5 million contract to develop SynCardia’s next-generation fully implantable Total Artificial Heart, marking a major step in advanced cardiovascular technology.

Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Capricorn Metals reports solid Q2 gold production at Karlawinda, maintaining momentum towards the upper end of its FY26 guidance while advancing major expansion projects.